Jane Street’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-409,843
| Closed | -$24.1M | – | 10431 |
|
|
2023
Q4 | $24.1M | Buy |
409,843
+222,917
| +119% | +$12.5M | 0.01% | 1122 |
|
|
2023
Q3 | $8.14M | Sell |
186,926
-42,957
| -19% | -$1.53M | ﹤0.01% | 2004 |
|
|
2023
Q2 | $8.31M | Buy |
229,883
+80,755
| +54% | +$3.33M | ﹤0.01% | 2118 |
|
|
2023
Q1 | $5.54M | Sell |
149,128
-41,092
| -22% | -$1.85M | ﹤0.01% | 2306 |
|
|
2022
Q4 | $8.62M | Buy |
190,220
+159,188
| +513% | +$10.3M | ﹤0.01% | 1787 |
|
|
2022
Q3 | $2.17M | Sell |
31,032
-53,614
| -63% | -$3.97M | ﹤0.01% | 4071 |
|
|
2022
Q2 | $5.68M | Buy |
84,646
+12,889
| +18% | +$820K | ﹤0.01% | 2481 |
|
|
2022
Q1 | $5.9M | Buy |
71,757
+25,399
| +55% | +$2.6M | ﹤0.01% | 2757 |
|
|
2021
Q4 | $6.8M | Buy |
46,358
+8,706
| +23% | +$1.35M | ﹤0.01% | 2395 |
|
|
2021
Q3 | $6.66M | Sell |
37,652
-10,352
| -22% | -$1.67M | ﹤0.01% | 2334 |
|
|
2021
Q2 | $7.75M | Buy |
48,004
+33,848
| +239% | +$5.43M | ﹤0.01% | 2023 |
|
|
2021
Q1 | $2.42M | Sell |
14,156
-11,361
| -45% | -$2.25M | ﹤0.01% | 3656 |
|
|
2020
Q4 | $5.61M | Sell |
25,517
-5,927
| -19% | -$1.28M | ﹤0.01% | 1995 |
|
|
2020
Q3 | $5.22M | Buy |
31,444
+26,223
| +502% | +$3.59M | ﹤0.01% | 1802 |
|
|
2020
Q2 | $596K | Buy |
+5,221
| New | +$506K | ﹤0.01% | 4806 |
|
|
2020
Q1 | – | Sell |
-3,424
| Closed | -$307K | – | 6163 |
|
|
2019
Q4 | $441K | Sell |
3,424
-10,814
| -76% | -$1.04M | ﹤0.01% | 3833 |
|
|
2019
Q3 | $1.11M | Buy |
+14,238
| New | +$1.34M | ﹤0.01% | 2484 |
|
|
2018
Q4 | – | Sell |
-7,067
| Closed | -$333K | – | 5923 |
|
|
2018
Q3 | $333K | Buy |
+7,067
| New | +$393K | ﹤0.01% | 4083 |
|
|
2017
Q4 | – | Sell |
-57,127
| Closed | -$668K | – | 5319 |
|
|
2017
Q3 | $668K | Buy |
+57,127
| New | +$331K | ﹤0.01% | 2764 |
|
|
2015
Q4 | – | Sell |
-13,863
| Closed | -$477K | – | 4580 |
|
|
2015
Q3 | $477K | Buy |
+13,863
| New | +$419K | ﹤0.01% | 2350 |
|
|
2014
Q3 | – | Sell |
-12,201
| Closed | -$244K | – | 3187 |
|
|
2014
Q2 | $244K | Buy |
12,201
+1,121
| +10% | +$21.6K | ﹤0.01% | 2017 |
|
|
2014
Q1 | $211K | Buy |
+11,080
| New | +$230K | ﹤0.01% | 2317 |
|
Other funds holding MRTX
Jane Street's MRTX Position: Q1 2024 in Review
Jane Street sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 409,843 shares — an estimated $24.1M sold.
Jane Street first reported a position in MRTX in Q1 2014 and held it in 22 quarters. The position peaked at $24.1M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Jane Street reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Jane Street sold 409,843 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $24.1M.
- Jane Street first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2014 and held it in 22 quarters.
- Jane Street's Mirati Therapeutics, Inc. Common Stock position peaked at $24.1M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.